A pilot randomized, multicenter, open-label, active comparator-controlled trial of a cp-690550-based regimen in de novo kidney allograft recipients

Trial Profile

A pilot randomized, multicenter, open-label, active comparator-controlled trial of a cp-690550-based regimen in de novo kidney allograft recipients

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 11 Jan 2008

At a glance

  • Drugs Ciclosporin; Tofacitinib
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 11 Jan 2008 Status changed from recruiting to withdrawn prior to recruitment "due to re-evaluation of the overall risks and benefits of the proposed regimen in Study A3921037, taking into consideration the emerging findings from ongoing and completed clinical trials".
    • 19 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top